Contract facts
FederalNo full NAICS 541714 intel page yet. Browse NAICS intelligence
TO CONDUCT A CLINICAL TRIAL TO ASSESS THE SAFETY, IMMUNOGENICITY, ANTIGEN DOSE, OF MATRIX-M ADJUVANT IN COMBINATION WITH U.S. DOMESTICALLY MANUFACTURED, EGG-BASED A/ASTRAKHAN/3212/2020 (H5N8) INFLUENZA VIRUS VACCINE IN HEALTHY ADULTS AND OLDER ADULTS is a federal award for Barda - Aspr / Daappo / Barda Dcma held by Sanofi Pasteur Inc. Estimated value $24.9M ($24.9M obligated). Current period of performance ends Sep 4, 2028. Place of performance: SWIFTWATER PA. Related solicitation RTOR #: 2025-00015.
TO CONDUCT A CLINICAL TRIAL TO ASSESS THE SAFETY, IMMUNOGENICITY, ANTIGEN DOSE, OF MATRIX-M ADJUVANT IN COMBINATION WITH U.S. DOMESTICALLY MANUFACTURED, EGG-BASED A/ASTRAKHAN/3212/2020 (H5N8) INFLUENZA VIRUS VACCINE IN HEALTHY ADULTS AND OLDER ADULTS
Recompete timing
PublicCurrent PoP ends Sep 4, 2028 (746 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 4, 2027.
Incumbent footprint
Public recordSanofi Pasteur Inc — $3.7B obligated across 396 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75A50125F61012?
75A50125F61012 (H5n8 and) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $24.9M, currently held by Sanofi Pasteur Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75A50125F61012?
Barda - Aspr / Daappo / Barda Dcma awarded 75A50125F61012 to Sanofi Pasteur Inc (potential $24.9M).
Who is the incumbent on 75A50125F61012?
Sanofi Pasteur Inc is the incumbent with $3.7B across 396 related awards in SCOUT’s public footprint. The current period of performance ends Sep 4, 2028.
When does Sanofi Pasteur Inc’s 75A50125F61012 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 4, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.